Translational Development Acquisition Corp. - Ordinary Shares (TDAC)
10.82
-0.02 (-0.18%)
NASDAQ· Last Trade: Jul 29th, 5:57 PM EDT
Detailed Quote
| Previous Close | 10.84 |
|---|---|
| Open | 10.84 |
| Bid | 10.80 |
| Ask | 10.86 |
| Day's Range | 10.79 - 10.84 |
| 52 Week Range | 10.32 - 10.90 |
| Volume | 75,761 |
| Market Cap | 55.61M |
| PE Ratio (TTM) | 0.4373 |
| EPS (TTM) | 24.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 21,527 |
Chart
News & Press Releases
TAIPEI, Taiwan and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Prologium Holding Inc. (“ProLogium” or the “Company”), a global leader in the innovation and manufacturing of next-generation lithium ceramic batteries, and Translational Development Acquisition Corp. (“TDAC”) (Nasdaq: TDAC), a special purpose acquisition company, today announced that ProLogium and TDAC have secured commitments for a $50 million primary capital investment from a consortium of existing ProLogium shareholders to support the previously announced business combination that would result in ProLogium becoming a publicly listed company (the “Transaction”).
By ProLogium Technology Co., Ltd. · Via GlobeNewswire · July 28, 2026
TAIPEI, Taiwan and NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- ProLogium Holding Inc. (“ProLogium” or the “Company”), a global leader in the innovation and manufacturing of next-generation solid-state batteries, and Translational Development Acquisition Corp. ("TDAC") (Nasdaq: TDAC), a special purpose acquisition company, today announced they have entered into a definitive agreement for a business combination that would result in ProLogium becoming a publicly listed company (the “Transaction”).
By ProLogium Technology Co., Ltd. · Via GlobeNewswire · May 27, 2026